[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: R-TPR-023: Day 0; It is administered as intravenous infusion in dose of 500 mg Bevacizumab should be mixed with 100 ml of 0.9% NaCl( standard of care).Control Intervention1: 0.9% NacL (100 ML): Day 0; standard of care alone group would receive only 100 ml of 0.9% NaCl", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: R-TPR-023: Day 0; It is administered as intravenous infusion in dose of 500 mg Bevacizumab should be mixed with 100 ml of 0.9% NaCl( standard of care).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: 0.9% NacL (100 ML): Day 0; standard of care alone group would receive only 100 ml of 0.9% NaCl", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 197, "treatment_name": "Bevacizumab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]